Cyto-Histological Correlation Analysis in the Diagnosis of Cervical Lesions: Cancer Prevention Clinic – Venezuela (2020-2024)
DOI:
https://doi.org/10.32635/2176-9745.RBC.2026v72n4.5696Keywords:
Cross-Sectional Studies, Papanicolaou Test, Biopsy, HPV, VenezuelaAbstract
Introduction: Cervical cancer is a global public health problem, particularly in low- and middle-income countries such as Venezuela. Although global incidence has decreased thanks to screening programs and vaccination against the human papillomavirus (HPV), in Venezuela it remains one of the leading causes of female morbidity and mortality. Objective: Correlate the diagnosis of cervical cytology with the findings of cervical biopsy. Method: Descriptive, cross-sectional, and observational study conducted in patients treated at the “Clínica de Prevención del Cáncer” from January 2020 to December 2024. A total of 2,163 cytologies were performed, identifying 122 patients with simultaneous cervical biopsies, who formed the final sample of this analysis. Results: The mean age was 43.3±12.6 years; results showed that 4.06% of the total cytologies presented some type of cellular alteration, the most frequent was LSIL (low-grade squamous intraepithelial lesion). On the other hand, 50.82% of the biopsies presented pathological lesions, and 18% corresponded to invasive carcinoma. The correlation between cytology and cervical biopsy demonstrated a sensitivity of 85.48%, a specificity of 41.67%, a positive predictive value of 60.23%, and a negative predictive value of 73.53%. Conclusion: Cervical cytology maintains a valid diagnostic performance in the clinical setting. However, the standardization of auxiliary methods such as colposcopy and molecular typing tests is recommended to increase specificity, optimize clinical management, and reduce unnecessary procedures.
Downloads
References
Organización Panamericana de la Salud. Una estrategia mundial para la eliminación del cáncer de cervicouterino [Internet]. Washington (DC): Organización Panamericana de la Salud; [acceso 2025 mayo 2]. Disponible en: https://www.paho.org/es/fin-cancer-cervicouterino
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today [Internet]. Lyon (FR): International Agency for Research on Cancer; 2024 [acceso 2025 mayo 2]. Disponible en: https://gco.iarc.who.int/today
Villalta D, Sajo-Castelli AM, Araya LE, et al. Boletín General [Internet]. Caracas: Sociedad Anticancerosa de Venezuela; 2024 [acceso 2025 mayo 2]. Disponible en: https://www.cancervenezuela.org/descargas/Boletin-General-2024.pdf
World Health Organization. Comprehensive cervical cancer control: a guide to essential practice [Internet]. 2. ed. Geneva: World Health Organization; 2014 [acceso 2025 jun 28]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/144785/9789241548953_eng.pdf
Karjane N, Ivey S. Cervical Cytology (Pap Smear) [Internet]. Medscape; 2024 [acceso 2025 jul 24]. Disponível em: https://emedicine.medscape.com/article/1947979-overview
Jones BA, Novis DA. Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996;120(6):523-31.
Cortiñas P, Ríos K, Sánchez L. Citología cervical como pesquisa: factores para mejorar la sensibilidad. Gac Med Caracas [Internet]. 2008;116(1):37-40 [acceso 2025 jul 24]. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0367-47622008000100006&lng=es
Wright TC, Stoler MH, Behrens CM, et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189-97. doi: https://doi.org/10.1016/j.ygyno.2014.11.076 DOI: https://doi.org/10.1016/j.ygyno.2014.11.076
Food and Drug Administration. ViraType Human HPV Typing Kit (P890064) [Internet]. 1991 nov 3 [acesso 2025 jul 24]. Disponível em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P890064
Food and Drug Administration. Digene HC2 High-Risk HPV DNA Test (P890064 S009) [Internet]. 2001 jan 10 [acesso 2025 jul 24]. Disponível em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P890064S009
Food and Drug Administration. Hologic Cervista HPV HR and Cervista HPV 16/18 (P080015) [Internet]. 2009 dez 3 [acesso 2025 jul 24]. Disponível em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P080015
Food and Drug Administration. Hologic APTIMA (P100042) [Internet]. 2011 oct 28 [acesso 2025 jul 24]. Disponível em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P100042
Food and Drug Administration. Roche Cobas HPV Test (P100020) [Internet]. 2011 abr 19 [acesso 2025 jul 24]. Disponível em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P100020
Food and Drug Administration. Roche Cobas HPV Test (P100020 S008) [Internet]. 2014 abr 24 [acesso 2025 jul 24]. Disponível em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P100020S008
Food and Drug Administration. BD Onclarity HPV (P160037) [Internet]. 2018 feb 12 [acesso 2025 jul 24]. Disponível em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160037
Food and Drug Administration. Roche Cobas HPV Test (P100020 S055) [Internet]. 2024 abr 24 [acesso 2025 jul 24]. Disponível em: https://www.fda.gov/medical-devices/recently-approved-devices/cobas-hpv-test-4800-system-p100020s055
Food and Drug Administration. BD Onclarity HPV Assay (P160037S017) [Internet]. 2024 maio 14 [acesso 2025 jul 24]. Disponível em: https://www.fda.gov/medical-devices/recently-approved-devices/bd-onclarity-hpv-assay-p160037s017
Food and Drug Administration. Teal Wand (DEN240045) [Internet]. 2025 abr 14 [acesso 2025 jul 24]. Disponível em: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN240045
Andermann A, Blancquaert I, Beauchamp S, et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86(4):317-9. doi: https://doi.org/10.2471/BLT.07.050112 DOI: https://doi.org/10.2471/BLT.07.050112
RStudio [Internet]. Version 2024.04.2+764. Boston: Posit Software, PBC. 2024 oct 1 - [acesso 2024 mar 1]. Disponível em: http://www.rstudio.com/ide
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74. doi: https://doi.org/10.2307/2529310 DOI: https://doi.org/10.2307/2529310
World Medical Association. Declaración de Helsinki de la AMM: principios éticos para las investigaciones médicas con participantes humanos [Internet]. Ferney-Voltaire: World Medical Association; 2024 [acceso 2025 jul 24]. Disponible en: https://www.wma.net/es/que-hacemos/etica-medica/declaracion-de-helsinki/
Centro Nacional de Bioética. Lineamientos y Estatutos de la Asociación Civil. Caracas: Universidad Central de Venezuela; 1996.
Ministerio del Poder Popular para Ciencia y Tecnología (VE). Código de Ética para la Vida. 2. ed. Caracas: Ministerio del Poder Popular para Ciencia, Tecnología e Industrias Intermedias; 2010.
Berrios JL, Mena Revollo LO. Correlación citológica, colposcópica e histológica de lesiones precancerígenas en cérvix. Rev Med La Paz [Internet]. 2020;26(1):24-31 [acceso 2025 jul 28]. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-89582020000100004&lng=es
Mayorga-Bautista CD, Hidalgo-Martínez SM, Romo-Rodríguez MR, et al. Concordancia de los hallazgos citológicos, colposcópicos e histológicos en lesiones premalignas del cuello uterino. Ginecol Obstet Mex. 2023;91(1):32-38.
Rivera TJA, Hernández JAS, Huerta PMI, et al. Infección por VPH y cáncer cervicouterino. Rev Mex Patol Clin [Internet]. 2005;52(4):222-33 [acceso 2025 jul 28]. Disponible en: https://www.imbiomed.com.mx/articulo.php?id=33752
Ouh YT, Park JJ, Kang M, et al. Discrepancy between cytology and histology in cervical cancer screening: a multicenter retrospective study (KGOG 1040). J Korean Med Sci. 2021;36(24):e164. doi: https://doi.org/10.3346/jkms.2021.36.e164 DOI: https://doi.org/10.3346/jkms.2021.36.e164
Torres Luna JD, Zapata Miranda JR, Duarte Muñoz FC, et al. Comparación entre citología y colposcopia para diagnóstico de neoplasia intraepitelial cervical: estudio de precisión diagnóstica. Rev Med Hondur. 2025;93(1):19-24. doi: https://doi.org/10.5377/rmh.v93i1.20637 DOI: https://doi.org/10.5377/rmh.v93i1.20637
Downloads
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.

This work is licensed under a Creative Commons Attribution 4.0 International License.
